Cargando…
Mission‐oriented translational cancer research – health economics
Health economics is an integrated aspect of all phases of mission‐oriented translational cancer research and should be considered an intrinsic component of any study aimed at improving outcomes for patients and intervention costs. Information about value and value for money of new options for preven...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396355/ https://www.ncbi.nlm.nih.gov/pubmed/30628161 http://dx.doi.org/10.1002/1878-0261.12440 |
_version_ | 1783399232828342272 |
---|---|
author | Jönsson, Bengt Sullivan, Richard |
author_facet | Jönsson, Bengt Sullivan, Richard |
author_sort | Jönsson, Bengt |
collection | PubMed |
description | Health economics is an integrated aspect of all phases of mission‐oriented translational cancer research and should be considered an intrinsic component of any study aimed at improving outcomes for patients and intervention costs. Information about value and value for money of new options for prevention and treatment is needed for decisions about their adoption and use by healthcare systems. |
format | Online Article Text |
id | pubmed-6396355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63963552019-03-11 Mission‐oriented translational cancer research – health economics Jönsson, Bengt Sullivan, Richard Mol Oncol Review Articles Health economics is an integrated aspect of all phases of mission‐oriented translational cancer research and should be considered an intrinsic component of any study aimed at improving outcomes for patients and intervention costs. Information about value and value for money of new options for prevention and treatment is needed for decisions about their adoption and use by healthcare systems. John Wiley and Sons Inc. 2019-02-20 2019-03 /pmc/articles/PMC6396355/ /pubmed/30628161 http://dx.doi.org/10.1002/1878-0261.12440 Text en © 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Articles Jönsson, Bengt Sullivan, Richard Mission‐oriented translational cancer research – health economics |
title | Mission‐oriented translational cancer research – health economics |
title_full | Mission‐oriented translational cancer research – health economics |
title_fullStr | Mission‐oriented translational cancer research – health economics |
title_full_unstemmed | Mission‐oriented translational cancer research – health economics |
title_short | Mission‐oriented translational cancer research – health economics |
title_sort | mission‐oriented translational cancer research – health economics |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396355/ https://www.ncbi.nlm.nih.gov/pubmed/30628161 http://dx.doi.org/10.1002/1878-0261.12440 |
work_keys_str_mv | AT jonssonbengt missionorientedtranslationalcancerresearchhealtheconomics AT sullivanrichard missionorientedtranslationalcancerresearchhealtheconomics |